Coastal Bridge Advisors, LLC Uro Gen Pharma Ltd. Transaction History

Coastal Bridge Advisors, LLC

$337 Million
Q1 2025

A detailed history of Coastal Bridge Advisors, LLC transactions in Uro Gen Pharma Ltd. stock. As of the latest transaction made, Coastal Bridge Advisors, LLC holds 37,000 shares of URGN stock, worth $656,750. This represents 0.12% of its overall portfolio holdings.

Number of Shares

37,000

Previous 39,000 5.13%

Holding current value

$656,750

Previous $415,000 1.45%

% of portfolio

0.12%

Previous 0.12%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 08, 2025	SELL	$9.27 - $12.13 $18,540 - $24,260	-2,000 Reduced 5.13%	37,000 $409,000
Q4 2024 Feb 14, 2025	SELL	$10.52 - $13.11 $15,780 - $19,665	-1,500 Reduced 3.7%	39,000 $415,000
Q3 2024 Nov 14, 2024	BUY	$12.7 - $17.92 $25,400 - $35,840	2,000 Added 5.19%	40,500 $514,000
Q2 2024 Aug 15, 2024	BUY	$12.72 - $19.2 $19,080 - $28,800	1,500 Added 4.05%	38,500 $646,000
Q1 2024 May 15, 2024	SELL	$13.81 - $19.33 $10,357 - $14,497	-750 Reduced 1.99%	37,000 $555,000
Q4 2023 Feb 15, 2024	SELL	$10.87 - $15.93 $8,152 - $11,947	-750 Reduced 1.95%	37,750 $566,000
Q3 2023 Nov 14, 2023	BUY	$8.84 - $22.64 $6,789 - $17,387	768 Added 2.04%	38,500 $539,000
Q2 2023 Aug 16, 2023	BUY	$8.75 - $14.29 $6,405 - $10,460	732 Added 1.98%	37,732 $390,000
Q2 2022 Aug 05, 2022	SELL	$5.12 - $8.74 $5,120 - $8,740	-1,000 Reduced 2.63%	37,000 $303,000
Q1 2022 May 13, 2022	SELL	$5.92 - $9.73 $213,120 - $350,280	-36,000 Reduced 48.65%	38,000 $331,000
Q4 2021 May 20, 2022	BUY	$9.03 - $19.13 $334,110 - $707,810	37,000 Added 100.0%	74,000 $1.02 Million
Q1 2020 May 14, 2020	BUY	$13.68 - $34.6 $236,773 - $598,856	17,308 Added 87.89%	37,000 $660,000
Q4 2019 Feb 13, 2020	BUY	$21.11 - $34.86 $42,220 - $69,720	2,000 Added 11.3%	19,692 $657,000
Q2 2019 Aug 13, 2019	BUY	$32.75 - $40.35 $327,238 - $403,177	9,992 Added 129.77%	17,692 $636,000
Q2 2019 Aug 07, 2019	SELL	$32.75 - $40.35 $75,325 - $92,805	-2,300 Reduced 23.0%	7,700 $636,000
Q1 2019 May 08, 2019	BUY	$35.47 - $54.55 $354,700 - $545,500	10,000 New	10,000 $369,000
Q3 2018 Nov 08, 2018	SELL	$41.65 - $51.7 $800,929 - $994,191	-19,230 Closed	0 $0
Q1 2018 May 11, 2018	SELL	$38.64 - $57.54 $743,085 - $1.11 Million	-19,231 Reduced 50.0%	19,230 $956,000
Q3 2017 Nov 13, 2017	BUY	$17.15 - $32.72 $659,606 - $1.26 Million	38,461	38,461 $1.21 Million

Others Institutions Holding URGN

# of Institutions

149

Shares Held

42.6M

Call Options Held

116K

Put Options Held

42.1K

View Full List

About UroGen Pharma Ltd.

Ticker URGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 22,740,500
Market Cap $404M
Description
UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead...

More about URGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Coastal Bridge Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Coastal Bridge Advisors, LLC with notifications on news.

Account

Coastal Bridge Advisors, LLC Uro Gen Pharma Ltd. Transaction History